Evidence mapPaperPMID 42403448Full record

ArticleAmerican journal of preventive cardiology2026

PREVENT vs PCE thresholds for coronary artery calcium referral: Detection-optimized strategies in ELSA-Brasil.

Daniel A Added, Fernando Y Cesena, Marcio H Miname, Henrique Takematsu, Itamar de Souza Santos, Isabela M Bensenor, Paulo A Lotufo, Raul D Santos

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel A AddedLipid Clinic, Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, SP, Brazil.
Fernando Y CesenaInstituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil.
Marcio H MinameLipid Clinic, Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, SP, Brazil.
Henrique TakematsuLipid Clinic, Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, SP, Brazil.
Itamar de Souza SantosCenter for Clinical and Epidemiological Research, University Hospital, University of São Paulo, 2565 Professor Lineu Prestes Avenue, São Paulo, SP 05508-000, Brazil.
Isabela M BensenorCenter for Clinical and Epidemiological Research, University Hospital, University of São Paulo, 2565 Professor Lineu Prestes Avenue, São Paulo, SP 05508-000, Brazil.
Paulo A LotufoCenter for Clinical and Epidemiological Research, University Hospital, University of São Paulo, 2565 Professor Lineu Prestes Avenue, São Paulo, SP 05508-000, Brazil.
Raul D SantosLipid Clinic, Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Risk equations estimate 10-year ASCVD risk but were not designed to guide coronary artery calcium (CAC) testing, although guidelines consider CAC for risk refinement in borderline or intermediate-risk adults. Objectives: To compare the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) with Pooled Cohort Equations (PCE) for detecting CAC, identifying optimized CAC referral thresholds. Methods: In a cross-sectional analysis of 3477 ASCVD-free ELSA-Brasil participants, 10-year ASCVD risk was estimated using both tools, and reclassification assessed. Discrimination for CAC >0 and CAC ≥100 Agatston units was compared using area under receiver operating characteristic curve (AUC-ROC). Prespecified thresholds (PCE 7.5%; PREVENT 3.7% in men, 4.9% in women) and Youden-derived cutpoints were evaluated for sensitivity, specificity, scanning proportion, and number needed to scan (NNS). Results: Discrimination for CAC ≥100 was similar (AUC 0.81 vs 0.80 for PCE and PREVENT, respectively; p > 0.05). Using standard thresholds (7.5% for PCE; 3.7%/4.9% for PREVENT in men/women), 36.5% vs 38.8% of with CAC ≥100 were classified below cutpoints, more often in women (70.8% vs 67.4%). Youden-derived thresholds (5.6% vs 2.7%) increased sensitivity (73.3% vs 78.4%) but reduced specificity (74.1% vs 66.7%) and expanded referral eligibility (30.6% vs 38.2%), respectively. Conclusions: Both tools showed comparable discrimination for CAC ≥100, but standard cutpoints miss individuals, especially women. Lower, optimized thresholds (PCE 5.6%; PREVENT 2.7%) may improve detection but warrant further evaluation.

Indexed as

Cardiovascular risk predictionDetection efficiencyImaging-based preventionPreventive cardiologyRisk stratificationSex-based analysis

Identifiers

PMID42403448
PMCPMC13329528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.